Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours

Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumour of the gastrointestinal tract. The advent of targeted kinase-inhibitors has revolutionised treatment strategies and clinical outcomes for patients with advanced GIST. In the majority of countries, sunitinib is the only a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SAPONARA, MARISTELLA, LOLLI, CRISTIAN, NANNINI, MARGHERITA, DI SCIOSCIO, VALERIO, SERRA, CARLA, MANDRIOLI, ANNA, PALLOTTI, MARIA CATERINA, BIASCO, GUIDO, PANTALEO, MARIA ABBONDANZA
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2014
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4156266/
https://ncbi.nlm.nih.gov/pubmed/25202412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2348
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge